NCT04726800View on ClinicalTrials.gov

Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Colorectal Cancer
Trial Locations (8)

Unknown

Akershus Univeristy Hospital, Oslo

Sahlgrenska University Hospital, Gothenburg

Skaraborg Hospital, Skövde

Capio Sankt Göran Hospital, Stockholm

Danderyd University Hospital, Stockholm

Ersta Hospital, Stockholm

Karolinska University Hospital, Stockholm

South Hospital, Stockholm

All Listed Sponsors
lead

Anna Martling

OTHER